Looking at Healthcare Trust of America's (NYSE:HR) mostly flat share price movement over the past three months, it is easy to think that there's nothing interesting about the stock. However, its financials look weak which could potentially mean that its stock could show weakness in the future given that stock performances are usually attached to a company's financial health in the long-term. Specifically, we decided to study Healthcare Trust of America's ROE in this article.
Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Simply put, it is used to assess the profitability of a company in relation to its equity capital.
See our latest analysis for Healthcare Trust of America
How To Calculate Return On Equity?
ROE can be calculated by using the formula:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
So, based on the above formula, the ROE for Healthcare Trust of America is:
2.9% = US$96m ÷ US$3.3b (Based on the trailing twelve months to March 2022).
The 'return' is the yearly profit. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.03.
Why Is ROE Important For Earnings Growth?
Thus far, we have learned that ROE measures how efficiently a company is generating its profits. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.
Healthcare Trust of America's Earnings Growth And 2.9% ROE
As you can see, Healthcare Trust of America's ROE looks pretty weak. Not just that, even compared to the industry average of 6.5%, the company's ROE is entirely unremarkable. Hence, the flat earnings seen by Healthcare Trust of America over the past five years could probably be the result of it having a lower ROE.
As a next step, we compared Healthcare Trust of America's net income growth with the industry and discovered that the industry saw an average growth of 11% in the same period.
NYSE:HR Past Earnings Growth July 23rd 2022
The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Is HR fairly valued? This infographic on the company's intrinsic value has everything you need to know.
Is Healthcare Trust of America Using Its Retained Earnings Effectively?
While the company did pay out a portion of its dividend in the past, it currently doesn't pay a dividend. We infer that the company has been reinvesting all of its profits to grow its business.
Conclusion
In total, we would have a hard think before deciding on any investment action concerning Healthcare Trust of America. As a result of its low ROE and lack of much reinvestment into the business, the company has seen a disappointing earnings growth rate. That being so, the latest industry analyst forecasts show that the analysts are expecting to see a huge improvement in the company's earnings growth rate. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
看看美国医疗信托公司(NYSE：HR)过去三个月基本持平的股价走势，很容易认为这只股票没有什么有趣的东西。然而，该公司的财务状况看起来很疲软，这可能意味着，鉴于股票表现通常与一家公司的长期财务健康状况有关，该公司的股票未来可能会表现出疲软。具体地说，我们决定在本文中研究美国净资产收益率的医疗信托。
股本回报率或净资产收益率是股东要考虑的一个重要因素，因为它告诉他们他们的资本再投资的效率。简而言之，它是用来评估一家公司相对于其权益资本的盈利能力。
查看我们对美国医疗信托基金的最新分析
如何计算股本回报率？
可使用以下公式计算净资产收益率：
股本回报率=(持续经营的)净利润？股东权益
因此，根据上述公式，美国医疗信托基金的净资产收益率为：
2.9%=9600万美元×33亿美元(基于截至2022年3月的12个月的往绩)。
“回报”就是年度利润。因此，这意味着股东每投资1美元，公司就会产生0.03美元的利润。
为什么净资产收益率对收益增长很重要？
到目前为止，我们已经了解到净资产收益率衡量的是一家公司创造利润的效率。我们现在需要评估公司将多少利润再投资或“保留”用于未来的增长，这就让我们对公司的增长潜力有了一个了解。假设其他条件相同，与没有相同特征的公司相比，拥有更高股本回报率和更高利润保留率的公司通常会有更高的增长率。
美国医疗信托的收益增长和2.9%的净资产收益率
正如你所见，美国净资产收益率(ROE)的医疗信托基金看起来相当疲软。不仅如此，即使与6.5%的行业平均水平相比，该公司的净资产收益率也完全不起眼。因此，过去五年美国医疗信托基金的收益持平，可能是因为它的净资产收益率较低。
作为下一步，我们将美国医疗信托公司的净收入增长与该行业进行了比较，发现该行业在同一时期的平均增长为11%。
纽约证券交易所：HR过去的收益增长2022年7月23日
赋予一家公司价值的基础在很大程度上与其盈利增长挂钩。投资者应该尝试确定预期的收益增长或下降是否已计入价格，无论是哪种情况。通过这样做，他们将知道股票是将进入清澈的蓝色水域，还是等待沼泽水域。人力资源是否得到公平的评价？这张关于公司内在价值的信息图包含了你需要知道的一切。
美国医疗信托基金是否有效地利用其留存收益？
虽然该公司过去确实支付了一部分股息，但目前不支付股息。我们推断，该公司一直在将所有利润进行再投资，以发展业务。
结论
总而言之，在决定对美国医疗信托公司采取任何投资行动之前，我们将经过深思熟虑。由于净资产收益率较低，对该业务的再投资不足，该公司的收益增长率令人失望。既然如此，最新的行业分析师预测显示，分析师们预计该公司的收益增长率将大幅提高。要了解更多有关该公司未来收益增长预测的信息，请查看以下内容免费报告分析师对该公司的预测，以了解更多信息。
对这篇文章有什么反馈吗？担心内容吗？ 保持联系直接与我们联系。或者，也可以给编辑组发电子邮件，地址是implywallst.com。
本文由Simply Wall St.撰写，具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论，我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议，也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意，我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
